Locus Biosciences
Locus Biosciences is a biotechnology company developing CRISPR-Cas3-engineered precision antibacterial products.
All edits
Edits on 16 Feb, 2024
Amy Sar
Edits on 18 Oct, 2023
Golden AI
Edits on 6 Sep, 2023
Katrina-Kay Pettitt
Edits made to:
Infobox (+1/-1 properties)
Infobox
Number of Employees (Ranges)
100 – 249
Number of Employees (Ranges)
50 – 99
Edits on 12 Jul, 2023
Amy Sar
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (+1/-2 properties)
Infobox
Official Website
Official Website
Edits on 23 May, 2023
' fill='white' fill-rule='nonzero'%3e%3cpath d='M52 12c-22.048 0-40 17.952-40 40 0 10.848 4.48 21.376 12.288 28.864 7.008 6.752 16.096 10.592 25.792 11.04.48.032.992.096 1.472.096H52c10.336 0 20.128-3.904 27.616-11.04C87.616 73.312 92 63.04 92 52c0-22.048-17.952-40-40-40zm26.912 65.056c-1.472-5.216-8.448-8.032-13.696-10.112l-1.792-.736C60 64.8 60 63.488 60 61.6c0-1.344.672-3.264 1.888-4.416 3.104-2.72 4.736-6.464 4.736-10.816 0-8.8-6.144-15.168-14.624-15.168-8.448 0-14.336 6.24-14.336 15.168 0 4.544 1.536 8.192 4.512 10.816 1.248 1.12 1.792 3.072 1.792 4.416 0 1.344 0 3.008-4.16 4.704-5.12 2.112-11.904 4.992-15.008 10.432C18.688 69.984 15.2 61.12 15.2 52c0-20.288 16.512-36.8 36.8-36.8 20.288 0 36.8 16.512 36.8 36.8 0 9.408-3.52 18.208-9.888 25.056z'/%3e%3c/g%3e%3c/g%3e%3c/svg%3e)
Deactivated User
Infobox
Founder
1
Type: Web page
Nick Taylor (@NickkTaylorrrr) / Twitter. twitter.com. https://twitter.com/NickkTaylorrrrEdits on 17 May, 2023
Katrina-Kay Pettitt
Katrina-Kay Pettitt
Edits on 5 May, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Wellfound ID
locus-biosciences
Edits on 5 Apr, 2023
Katrina-Kay Pettitt
Edits on 16 Mar, 2023
Katrina-Kay Pettitt
Katrina-Kay Pettitt
Edits on 23 Feb, 2023
Katrina-Kay Pettitt
Edits on 27 Jan, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Investors
1
Type: General
Invested in. https://angel.co/u/scott-hatawayEdits on 21 Jan, 2023
Golden AI
Edits made to:
Infobox (+2/-2 properties)
Infobox
Latest Funding Round Date
November 2020
Latest Funding Round Amount (USD)
12,500,000
Latest Funding Round Date
May 18, 2022
Latest Funding Round Amount (USD)
35,000,000
Golden AI
Infobox
Funding Rounds
1
Author(s): Locus Biosciences
Date: May 18, 2022
Type: Web page
Locus Biosciences Announces $35 Million Financing. GlobeNewswire News Room. https://www.globenewswire.com/news-release/2022/05/18/2445897/0/en/Locus-Biosciences-Announces-35-Million-Financing.htmlEdits on 19 Sep, 2022
Katrina-Kay Pettitt
Edits on 28 Jul, 2022
Golden AI
Edits made to:
Article
Article
Locus Biosciences is a biotechnology company headquartered in Raleigh, North Carolina and was founded in 2015 by Charles Gersbach, Chase Beisel, Dave Ousterout, Nick Taylor, Paul Garofolo, and Rodolphe Barrangou.
On November 14, 2017 Locus Biosciences completed their series A funding round with $19 million in funding from Artis Ventures (lead investor), Starlight Ventures, North Carolina Biotechnology Center, and Abstract Ventures.
1
Date: 2015
Type: Web page
Locus Biosciences | Crunchbase. Crunchbase. https://www.crunchbase.com/organization/locus-biosciences2
Date: November 14, 2017
Type: Web page
Series A - Locus Biosciences - 2017-11-14 | Crunchbase. Crunchbase. https://www.crunchbase.com/funding_round/locus-biosciences-series-a--117e87feGolden AI
Infobox
Funding rounds
1
Type: Web page
Locus Biosciences - Funding. Crunchbase. https://www.crunchbase.com/organization/locus-biosciences/company_financialsEdits on 25 Jul, 2022
Amy Sar
Find more companies like Locus Biosciences
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
By using this site, you agree to our Terms of Service.
- Create Issue
- View Changes
- Create Issue
- View Changes
- Create Issue
- View Changes
- Create Issue
- View Changes
- Create Issue
- View Changes
- Create Issue
- View Changes
- Create Issue
- View Changes
- Create Issue
- View Changes
- Create Issue
- View Changes
- Create Issue
- View Changes
- Create Issue
- View Changes
- Create Issue
- View Changes
- Create Issue
- View Changes
- Create Issue
- View Changes
- Create Issue
- View Changes
- Create Issue
- View Changes
- Create Issue
- View Changes
- Create Issue
- View Changes
- Create Issue
- View Changes
- Create Issue
- View Changes
- Content Issue